248 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

TVTX

Travere Therapeutics
US$12.8433.8%-7.0%US$983.7mUS$17.40PS5.5xE68.8%n/a

GTHX

G1 Therapeutics
US$7.130.6%332.1%US$377.6mUS$7.15PS6.5xE57.8%n/a

TGTX

TG Therapeutics
US$23.534.1%119.7%US$3.4bUS$33.75PE35.3xE43.5%n/a

ASND

Ascendis Pharma
US$114.76-14.8%11.9%US$6.7bUS$182.64PS18.8xE68.4%n/a

SRPT

Sarepta Therapeutics
US$126.94-6.0%5.9%US$12.2bUS$193.59PE256xE44.9%n/a

IMGN

ImmunoGen
US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

SGEN

Seagen
US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

IVVD

Invivyd
US$0.905.7%-52.4%US$107.7mUS$8.65PS47.5xE70.4%n/a

ARDX

Ardelyx
US$5.691.1%17.8%US$1.3bUS$11.28PS6.4xE65.9%n/a

SMCI

Super Micro Computer
US$412.72-6.6%54.2%US$24.0bUS$823.46PE20xE27.1%n/a

CLNN

Clene
US$5.82-1.7%-53.9%US$37.2mUS$53.00PS85.2xE62.1%n/a

FOLD

Amicus Therapeutics
US$11.25-3.3%-15.6%US$3.4bUS$17.25PS7.3xE61.8%n/a

APLS

Apellis Pharmaceuticals
US$39.181.0%-7.2%US$4.9bUS$69.82PS7.6xE67.8%n/a

BPMC

Blueprint Medicines
US$85.99-7.1%62.8%US$5.5bUS$127.35PS15xE67.4%n/a

MAX

MediaAlpha
US$16.85-2.3%113.8%US$1.2bUS$24.00PS1.9xE61.3%n/a

ISEE

IVERIC bio
US$39.950.9%236.3%US$5.5bUS$40.00PB11.6xE59.0%n/a

PTC

PTC
US$166.94-3.8%19.1%US$20.2bUS$198.66PE67.9xE23.9%n/a

URGN

UroGen Pharma
US$13.42-1.0%-16.9%US$562.2mUS$43.10PS6.6xE55.1%n/a

ENSC

Ensysce Biosciences
US$0.34-6.8%-81.6%US$3.9mUS$9.05PS2.6xE96.3%n/a

CARG

CarGurus
US$26.48-5.1%45.8%US$2.8bUS$28.88PS3.1xE51.5%n/a

HALO

Halozyme Therapeutics
US$59.26-3.2%52.3%US$7.5bUS$59.10PE22.3xE22.0%n/a

WULF

TeraWulf
US$4.2411.0%139.5%US$1.5bUS$6.56PS13.5xE108.6%n/a

MGTX

MeiraGTx Holdings
US$4.074.1%-32.2%US$311.1mUS$20.60PS38.8xE7.8%n/a

SLNO

Soleno Therapeutics
US$49.434.6%1,135.8%US$1.9bUS$70.29PB6.8xE68.2%n/a
Page 1 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.